跳至主要内容
临床试验/NL-OMON55874
NL-OMON55874尚未招募不适用

Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients. - OPTI-CLOT: TARGET

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 64(—)

入选标准

  • - Hemophilia A and B patients of all ages on prophylaxis;
  • - Prophylaxis with SHL factor concentrates or EHL factor concentrates;
  • - Written (parental) informed consent, according to local law and regulations

排除标准

  • - Patients with other congenital or acquired hemostatic abnormalities;
  • - General medical conditions which may interfere with participation in the
  • - Inability to adhere to prophylaxis and/ or inability to keep detailed logs on
  • infusion and bleeding episodes;
  • - Withdrawal of (parental) informed consent.

研究者

相似试验